糖、脂代谢及氧化应激与糖尿病肾病的相关性

被引:26
作者
刘华 [1 ]
齐磊 [2 ]
白洁 [2 ]
机构
[1] 云南省第一人民医院干部保健科
[2] 昆明理工大学生命科学与技术学院
关键词
糖尿病肾病; 硫氧还蛋白; 氧化应激;
D O I
10.13488/j.smhx.2011.01.021
中图分类号
R587.2 [糖尿病性昏迷及其他并发症];
学科分类号
100201 [内科学];
摘要
糖尿病肾病是糖尿病的主要并发症之一。近年来,糖尿病肾病的发病率呈逐渐上升趋势。研究发现,糖、脂代谢与糖尿病肾病的发生密切相关,而氧化应激也在糖、脂代谢异常中起重要作用。本文综述了有关糖、脂代谢与糖尿病肾病相关性研究,以及硫氧还蛋白及硫氧还蛋白结合蛋白2在糖尿病肾病发生中的作用。
引用
收藏
页码:78 / 81
页数:4
相关论文
共 11 条
[1]
氧化应激对糖尿病肾病时细胞、细胞外基质及血管通透性的影响机制 [J].
郑美玲 ;
樊均明 .
中国组织工程研究与临床康复, 2007, (25) :4988-4991
[2]
糖尿病性微血管病的临床病理生理 [J].
金惠铭 ;
胡仁明 .
中国病理生理杂志, 2007, (02) :399-402
[3]
糖尿病氧化应激的研究进展及其与糖尿病肾病的关系 [J].
朱斌 ;
沈汉超 .
国外医学(泌尿系统分册), 2004, (06) :818-822
[4]
氧化应激与糖尿病肾病的研究进展 [J].
杨光伟 ;
叶山东 .
国际泌尿系统杂志, 2007, (05)
[5]
p38 MAPK pathway is involved in high glucose-induced thioredoxin interacting protein induction in mouse mesangial cells [J].
Ren, Yunzhuo ;
Shi, Yonghong ;
Wang, Yuehua ;
Li, Yingmin ;
Wu, Shuhui ;
Li, Hang ;
Zhang, Yanling ;
Duan, Huijun .
FEBS LETTERS, 2010, 584 (15) :3480-3485
[6]
Therapeutic Potential of Aleglitazar; a New Dual PPAR-α/γ Agonist.[J].Matthew Cavender;A. Lincoff.American Journal of Cardiovascular Drugs.2010, 4
[7]
Emerging role of PPAR ligands in the management of diabetic nephropathy [J].
Balakumar, Pitchai ;
Arora, Mandeep Kumar ;
Singh, Manjeet .
PHARMACOLOGICAL RESEARCH, 2009, 60 (03) :170-173
[8]
Recent advances in pharmacotherapy for diabetic nephropathy: Current perspectives and future directions [J].
Balakumar, Pitchai ;
Arora, Mandeep Kumar ;
Ganti, Subrahmanya S. ;
Reddy, Jayarami ;
Singh, Manjeet .
PHARMACOLOGICAL RESEARCH, 2009, 60 (01) :24-32
[9]
Ameliorative effect of combination of benfotiamine and fenofibrate in diabetes-induced vascular endothelial dysfunction and nephropathy in the rat [J].
Pitchai Balakumar ;
Vishal Arvind Chakkarwar ;
Manjeet Singh .
Molecular and Cellular Biochemistry, 2009, 320 :149-162
[10]
Telmisartan; an Angiotensin II Type 1 Receptor Blocker; Inhibits Advanced Glycation End-product (AGE)-induced Monocyte Chemoattractant Protein-1 Expression in Mesangial Cells through Downregulation of Receptor for AGEs via Peroxisome Proliferator-activated Receptor-γ Activation.[J].T Matsui;S Yamagishi;S Ueda;K Nakamura;T Imaizumi;M Takeuchi;H Inoue.Journal of International Medical Research.2007, 4